137 related articles for article (PubMed ID: 1387023)
1. Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1992 May; 106(1):180-6. PubMed ID: 1387023
[TBL] [Abstract][Full Text] [Related]
2. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by phosphoramidon of the regional haemodynamic effects of proendothelin-2 and -3 in conscious rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1992 Oct; 107(2):584-90. PubMed ID: 1422599
[TBL] [Abstract][Full Text] [Related]
4. The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1-38] in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T
Br J Pharmacol; 1991 Aug; 103(4):2009-15. PubMed ID: 1912989
[TBL] [Abstract][Full Text] [Related]
5. Cross tachyphylaxis to endothelin isopeptide-induced hypotension: a phenomenon not seen with proendothelin.
Le Monnier de Gouville AC; Cavero I
Br J Pharmacol; 1991 Sep; 104(1):77-84. PubMed ID: 1786522
[TBL] [Abstract][Full Text] [Related]
6. Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T; Davenport AP; Edvinsson L
Br J Pharmacol; 1994 Jun; 112(2):477-86. PubMed ID: 8075866
[TBL] [Abstract][Full Text] [Related]
7. Coeliac haemodynamic effects of endothelin-1, endothelin-3, proendothelin-1 [1-38] and proendothelin-3 [1-41] in conscious rats.
Gardiner SM; Kemp PA; Compton AM; Bennett T
Br J Pharmacol; 1992 Jun; 106(2):483-8. PubMed ID: 1393273
[TBL] [Abstract][Full Text] [Related]
8. Effects of the ECE/NEP inhibitor CGS 34225 on the big ET-1-induced pressor response and plasma atrial natriuretic peptide concentration in conscious rats.
Trapani AJ; Beil ME; Bruseo CW; Fink CA; Hoyer D; Savage P; Jeng AY
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():102S-106S. PubMed ID: 12193065
[TBL] [Abstract][Full Text] [Related]
9. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
[TBL] [Abstract][Full Text] [Related]
10. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
Seymour AA; Asaad MM; Abboa-Offei BE; Smith PL; Rogers WL; Dorso CR
J Pharmacol Exp Ther; 1996 Feb; 276(2):708-13. PubMed ID: 8632340
[TBL] [Abstract][Full Text] [Related]
11. Regional haemodynamic effects of endothelin-1 and endothelin-3 in conscious Long Evans and Brattleboro rats.
Gardiner SM; Compton AM; Bennett T
Br J Pharmacol; 1990 Jan; 99(1):107-12. PubMed ID: 2139584
[TBL] [Abstract][Full Text] [Related]
12. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
[TBL] [Abstract][Full Text] [Related]
13. CGS 34043: a non-peptidic, potent and long-acting dual inhibitor of endothelin converting enzyme-1 and neutral endopeptidase 24.11.
Trapani AJ; De Lombaert S; Beil ME; Bruseo CW; Savage P; Chou M; Jeng AY
Life Sci; 2000; 67(9):1025-33. PubMed ID: 10954036
[TBL] [Abstract][Full Text] [Related]
14. Potentiation of natriuretic peptides by neutral endopeptidase inhibitors.
Seymour AA; Abboa-Offei BE; Smith PL; Mathers PD; Asaad MM; Rogers WL
Clin Exp Pharmacol Physiol; 1995 Jan; 22(1):63-9. PubMed ID: 7768036
[TBL] [Abstract][Full Text] [Related]
15. Regional haemodynamic responses to intravenous and intraarterial endothelin-1 and big endothelin-1 in conscious rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1993 Dec; 110(4):1532-6. PubMed ID: 8306098
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of brain natriuretic peptides by SQ 28,603, an inhibitor of neutral endopeptidase 3.4.24.11, in monkeys and rats.
Seymour AA; Asaad MM; Abboa-Offei BE; Rovnyak PL; Fennell S; Rogers WL
J Pharmacol Exp Ther; 1992 Jul; 262(1):60-70. PubMed ID: 1385630
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of captopril on regional haemodynamic responses to angiotensin I and bradykinin in conscious rats.
Gardiner SM; Kemp PA; Bennett T
Br J Pharmacol; 1993 Mar; 108(3):769-75. PubMed ID: 8467363
[TBL] [Abstract][Full Text] [Related]
18. Effects of neutral endopeptidase inhibition on the clearance of exogenously administered endothelin in Sprague-Dawley rats.
Asaad MM; Dorso CR; Moreland SM
J Cardiovasc Pharmacol; 1993 Apr; 21(4):633-6. PubMed ID: 7681910
[TBL] [Abstract][Full Text] [Related]
19. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors.
Seymour AA; Norman JA; Asaad MM; Fennell SA; Abboa-Offei B; Little DK; Kratunis VJ; Delaney NG; Hunt JT; Di Donato G
J Pharmacol Exp Ther; 1991 Mar; 256(3):1002-9. PubMed ID: 1826031
[TBL] [Abstract][Full Text] [Related]
20. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
Seymour AA; Norman JA; Asaad MM; Fennell SA; Little DK; Kratunis VJ; Rogers WL
J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
